Mars Completes Acquisition of VCA Inc.

Mars Incorporated successfully completes $9.1 billion acquisition of VCA Inc., strengthening its pet care portfolio.

By Sneha Tete, Integrated MA, Certified Relationship Coach
Created on

Mars, Incorporated Completes Acquisition of VCA Inc.

On September 12, 2017, Mars, Incorporated and VCA Inc. announced the successful completion of Mars’ previously announced acquisition of VCA. This landmark transaction, valued at approximately $9.1 billion, represents one of the most significant acquisitions in the pet care industry. The deal was initially announced on January 9, 2017, when Mars and VCA entered into an agreement for Mars to acquire VCA at $93 per share, a move that would reshape the landscape of veterinary services and animal healthcare across North America.

Transaction Overview and Details

The acquisition was structured as a comprehensive integration of one of North America’s largest animal hospital networks into Mars Petcare, a subsidiary of the Mars conglomerate. The transaction included the assumption of approximately $1.4 billion in outstanding debt, bringing the total enterprise value to $9.1 billion. This acquisition marked a pivotal moment in Mars’ strategic expansion of its pet care business, which already included established veterinary service providers such as Banfield Pet Hospitals, BluePearl Specialty and Emergency Pet Hospitals, and Pet Partners Veterinary Hospitals.

The completion of this acquisition represented the culmination of several months of regulatory review and approval processes. Both companies’ boards of directors had approved the deal, and it successfully navigated through the necessary regulatory channels to achieve final completion. The transaction demonstrated Mars’ commitment to consolidating and strengthening its position in the pet healthcare sector, which has experienced significant growth as pet owners increasingly seek premium veterinary services for their animals.

VCA’s Position Within Mars Petcare

Operational Independence and Leadership

Following the acquisition’s completion, VCA was positioned to operate as a distinct and separate business within Mars Petcare, maintaining its operational independence while benefiting from Mars’ resources and strategic support. This structure allowed VCA to leverage its established reputation and operational excellence while gaining access to Mars’ global infrastructure and capabilities. Bob Antin, a co-founder of VCA, continued to lead the company as Chief Executive Officer, ensuring continuity in leadership and vision. This decision reflected Mars’ confidence in VCA’s management team and its commitment to preserving the company’s culture and operational effectiveness.

VCA remained headquartered in Los Angeles, California, preserving its West Coast roots and maintaining its connection to the market where it had built its reputation over decades. The decision to keep VCA’s headquarters in Los Angeles underscored Mars’ recognition of VCA’s strong local presence and the importance of maintaining its established organizational structure. With more than 25,000 team members, VCA represented a significant workforce that would contribute to Mars’ overall pet care strategy.

Integration with Mars Petcare Portfolio

Within the Mars Petcare division, VCA joined a portfolio of complementary veterinary services businesses. The integration strategy positioned VCA alongside Banfield Pet Hospitals, BluePearl Specialty and Emergency Pet Hospitals, and Pet Partners Veterinary Hospitals. This constellation of veterinary service providers created a comprehensive network capable of delivering a wide range of pet healthcare services, from routine preventative care to specialized emergency and surgical services.

The strategic positioning of these entities within Mars Petcare reflected a coordinated approach to expanding Mars’ presence in the veterinary services market. By maintaining separate operational identities while fostering collaboration, Mars created opportunities for these businesses to cross-reference, share best practices, and coordinate care for pet owners who might benefit from multiple service offerings across the portfolio.

VCA’s Network and Operations Before Acquisition

Scope of VCA’s Animal Hospital Chain

Prior to the acquisition, VCA operated an extensive network of nearly 800 animal hospitals and 60 diagnostic laboratories throughout the United States and Canada. This sprawling network positioned VCA as one of North America’s largest providers of animal healthcare services. The company employed 23,000 people, including approximately 1,400 in the Los Angeles area, making it a significant employer in the pet healthcare sector. VCA’s 2015 revenue reached $2.1 billion, demonstrating the substantial scale and financial performance of the organization.

The geographic distribution of VCA’s hospitals and diagnostic laboratories provided extensive coverage across North America, with California being the company’s largest market. This geographic reach, combined with its diagnostic laboratory network, enabled VCA to offer comprehensive veterinary services spanning preventative care, emergency treatment, surgical services, and specialized diagnostics. The breadth of VCA’s service offerings positioned the company as a leader in the veterinary services market, capable of addressing diverse pet healthcare needs.

Reputation and Service Quality

VCA’s flagship hospital in West Los Angeles exemplified the company’s commitment to advanced veterinary care and comprehensive services. This facility offered 24-hour emergency care, a team of surgeons, a dedicated cancer center, multiple surgical suites, and a physical therapy center. Such specialized facilities demonstrated VCA’s investment in cutting-edge veterinary medicine and its dedication to providing comprehensive care options for pet owners seeking advanced treatments for their animals.

The company’s growth trajectory reflected increasing consumer demand for premium pet healthcare services. VCA’s revenue grew from $1.5 billion in 2011 to $2.1 billion in 2015, while profit increased from $100 million to $216.1 million during the same period. This growth trajectory demonstrated the resilience of VCA’s business model and its ability to capitalize on growing consumer willingness to invest in pet healthcare.

Growth Strategy and Acquisitions

Consolidation and Expansion Timeline

Over the three decades preceding the Mars acquisition, VCA executed a strategic consolidation strategy that built the company into a leading veterinary services provider. Through a series of acquisitions, VCA combined independent animal hospitals, diagnostic laboratories, and veterinary practices into an integrated network. This consolidation approach enabled VCA to expand its geographic reach, broaden its service offerings, and achieve operational efficiencies through standardized processes and shared resources.

VCA’s acquisition strategy extended beyond traditional veterinary hospitals and diagnostic services. In 2014, the company acquired Camp Bow Wow, a dog day-care chain, demonstrating its vision for a comprehensive pet care ecosystem encompassing hospitalization, diagnostics, boarding, and daycare services. This diversified approach to acquisitions reflected VCA’s understanding of evolving pet owner expectations and the growing market for comprehensive pet care solutions.

Market Position and Competitive Landscape

Despite VCA’s significant market presence, the North American veterinary services market remained highly fragmented. The market included approximately 26,000 animal hospitals across North America, with the combined Mars-VCA entity representing roughly 6.5% of total locations. This competitive landscape, while dominated by numerous independent practitioners and smaller chains, created ongoing consolidation opportunities and justified Mars’ strategic investment in VCA as a platform for future growth.

Regulatory Approval and Antitrust Considerations

Federal Trade Commission Review

The Mars acquisition of VCA underwent regulatory scrutiny by the Federal Trade Commission (FTC) to assess potential antitrust implications. The FTC evaluated whether the combined entity’s market position would substantially lessen competition in specialty and emergency veterinary services across specific geographic markets. The regulatory review identified potential competitive concerns in certain localities where Mars’ existing BluePearl Specialty and Emergency Pet Hospitals competed directly with VCA’s specialty and emergency services.

Consent Order and Divestitures

To address FTC concerns and obtain regulatory clearance, Mars agreed to divest 12 veterinary clinics located across the United States that provide specialty and emergency services. These clinics were sold to three approved divestiture buyers: National Veterinary Associates, Pathway Partners Vet Management Company, and PetVet Care Centers. The divestiture requirement ensured that the combined entity would not eliminate head-to-head competition in specialty and emergency veterinary services across 10 U.S. localities identified by the FTC.

Beyond the clinic divestitures, the consent order imposed additional conditions on Mars to preserve competitive dynamics in the veterinary services market. Mars was required to secure all necessary third-party consents, assignments, releases, and waipers to permit divestiture buyers to operate the clinics effectively. The company was also required to provide reasonable financial incentives to key employees at divested clinics to ensure continuity of operations and service quality. For one year following the order’s effective date, Mars was prohibited from entering contracts with specialty or emergency veterinarians affiliated with divested clinics, preventing post-acquisition anti-competitive conduct. Additionally, Mars faced a 10-year reporting requirement to notify the FTC of any plans to acquire additional specialty or emergency veterinary clinics in specified geographic areas.

Strategic Vision and Future Direction

Mars Leadership Perspective

Poul Weihrauch, Mars Global Petcare President, articulated the strategic rationale for the acquisition: “VCA’s partnerships with veterinarians and pet care providers, as well as their breadth and expertise in veterinary services, diagnostics and technology, will position all of us to deliver more comprehensive care and continue on our journey supporting our Purpose: A BETTER WORLD FOR PETS.” This statement reflected Mars’ vision for leveraging VCA’s capabilities to expand its pet care portfolio and enhance service delivery across its veterinary businesses.

The acquisition aligned with Mars’ broader corporate philosophy and operational principles. The Mars Five Principles—Quality, Responsibility, Mutuality, Efficiency, and Freedom—provided a framework for integrating VCA into Mars’ operations while maintaining the acquired company’s distinct identity and operational excellence. Mars’ commitment to these principles suggested that the company viewed the VCA acquisition as an opportunity to advance its mission of supporting pet welfare while delivering growth and value to stakeholders.

Synergies and Future Opportunities

The combination of Mars’ resources, distribution capabilities, and pet food brands with VCA’s extensive hospital network and diagnostic laboratories created opportunities for cross-selling, operational efficiency, and enhanced service delivery. Mars’ existing pet food brands—Pedigree, Whiskas, and Sheba—could be integrated with VCA’s veterinary services to provide pet owners with integrated nutrition and healthcare solutions. The synergies extended beyond product offerings to include operational best practices, technology sharing, and coordinated expansion strategies across North America.

Company Background and Context

Mars, Incorporated Overview

Mars, Incorporated operates as a privately held global conglomerate headquartered in McLean, Virginia, with annual sales of $35 billion and operations spanning more than 80 countries. Beyond its renowned confectionery brands including M&M’s, Snickers, Milky Way, Skittles, Dove chocolate, and Wrigley’s gum, Mars maintains a substantial and growing pet care business. The company’s pet care division encompasses pet food manufacturers, veterinary hospital networks, and veterinary services providers, positioning Mars as a comprehensive pet care company addressing pet nutrition, healthcare, and wellness across multiple channels.

VCA’s Founding and Evolution

Originally incorporated as Veterinary Centers of America Inc., VCA was founded in 1986 by a group of entrepreneurs including brothers Robert and Arthur Antin. Robert Antin served as Chief Executive Officer while Arthur Antin held the position of Chief Operating Officer. Over its first three decades, VCA transformed from a startup into a leading consolidator of veterinary practices and diagnostic laboratories. The company’s growth reflected both organic expansion and strategic acquisitions that built the network into one of North America’s largest animal hospital chains. The founders’ involvement in VCA’s leadership through the acquisition process demonstrated their confidence in the company’s future under Mars ownership and their desire to ensure continuity in VCA’s mission and values.

Frequently Asked Questions

Q: What was the total value of the Mars acquisition of VCA?

A: Mars acquired VCA for approximately $9.1 billion, with the deal structured at $93 per share and including the assumption of $1.4 billion in outstanding debt.

Q: How many animal hospitals did VCA operate?

A: Prior to the acquisition, VCA operated nearly 800 animal hospitals and 60 diagnostic laboratories throughout the United States and Canada.

Q: Did VCA maintain its operational independence after the acquisition?

A: Yes, VCA operates as a distinct and separate business within Mars Petcare, maintaining its Los Angeles headquarters and operational independence under CEO Bob Antin’s leadership.

Q: What regulatory approvals were required for the acquisition?

A: The acquisition required Federal Trade Commission approval, with Mars agreeing to divest 12 specialty and emergency veterinary clinics to address antitrust concerns in specific geographic markets.

Q: How many employees did VCA have at the time of acquisition?

A: VCA employed more than 25,000 team members across its operations, including approximately 1,400 in the Los Angeles area.

References

  1. Candy maker Mars is buying L.A. animal hospital chain VCA for $7.7 billion — Los Angeles Times. 2017-01-09. https://www.latimes.com/business/la-fi-vca-mars-20170109-story.html
  2. Mars, Incorporated Completes Acquisition of VCA Inc. — VCA Hospitals Press Center. 2017-09-12. https://vcahospitals.com/press-center/vca-news/mars-acquisition
  3. FTC Requires Mars to Divest 12 Veterinary Clinics as a Condition of Acquiring Pet Care Company VCA Inc — Federal Trade Commission. 2017-08-17. https://www.ftc.gov/news-events/news/press-releases/2017/08/ftc-requires-mars-divest-12-veterinary-clinics-condition-acquiring-pet-care-company-vca-inc
  4. Mars, Incorporated Completes Acquisition of VCA Inc. — PR Newswire. 2017-09-12. https://www.prnewswire.com/news-releases/mars-incorporated-completes-acquisition-of-vca-inc-300517872.html
Sneha Tete
Sneha TeteBeauty & Lifestyle Writer
Sneha is a relationships and lifestyle writer with a strong foundation in applied linguistics and certified training in relationship coaching. She brings over five years of writing experience to fluffyaffair,  crafting thoughtful, research-driven content that empowers readers to build healthier relationships, boost emotional well-being, and embrace holistic living.

Read full bio of Sneha Tete